HSS ProService’s emergence as a fully digitised business has been underpinned by a marketplace system built on functional programming in Scala and Cats, plus agentic artificial intelligence (AI), to ...

The anti-CD20 therapeutic antibody obinutuzumab (Gazyva/Gazyvaro) significantly reduces multiple measures of disease activity when compared with placebo in people with active systemic lupus ...

Erin Johnson was in middle school when she began experiencing severe exhaustion, joint pain, and skin rashes. She initially thought it was due to over-practicing as a member of the drill team. “My ...

Jake Fillery is an Evergreen Editor for GameRant who has been writing lists, guides, and reviews since 2022. With thousands of engaging articles and guides, Jake loves conversations surrounding all ...

Shontia Matlock was 19 and pregnant when she was diagnosed with lupus, a chronic autoimmune disease that can cause fatigue, joint pain, and skin changes. It wasn’t a total shock. “Everybody in my ...

Lupus is enigmatic. It can be both mild and severe, visible and hidden, and most importantly, misdiagnosed. That complexity makes it hard to detect and treat — and even harder to track. Reports ...

Amgen’s bad luck in lupus may finally be coming to an end. Daxdilimab, a monoclonal antibody acquired from Horizon Therapeutics in 2023, hit the primary endpoint in a phase 2 trial for discoid lupus ...

Hospital for Special Surgery (HSS) today announced the appointment of Anca Dinu Askanase, MD, MPH, as the new Chair of the Department of Medicine and Chief of the Division of Rheumatology, effective ...

New York City-based Hospital for Special Surgery appointed Anca Dinu Askanase, MD, as chair of the department of medicine and chief of the division of rheumatology, effective in April. Dr. Askanase ...

Jupiter Medical Center is partnering with the Hospital for Special Surgery (HSS) to expand orthopedic care. The alliance allows HSS, the nation's top orthopedic hospital, to perform inpatient ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the self-administered drug formulation in lupus patients with a positive phase ...